
Treatment of active psoriatic arthritis with the PPAR ligand pioglitazone: an open-label pilot study
Immunological consequences of thalidomide treatment in Sjögren’s syndrome
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis

Infectious origin of the antiphospholipid syndrome

HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis

How aggressive should initial therapy for rheumatoid arthritis be?
SAPHO syndrome and pamidronate revisited
SAPHO syndrome and pamidronate revisited: reply
